HDAC2 and neoplasm: Preliminary experiments did not yield differences in survival of tumor‐bearing mice and the lack of changes in HDAC2 and TAGLN expression among treatment groups as a pharmacodynamic study suggested that ineffective drug concentrations were achieved (Figure S7D,E, Supporting Information).